Menu
Oslo, 12 December 2024. Reference is made to the announcement by Thor Medical ASA (the "Company") earlier today, 12 December 2024, regarding key information on a potential subsequent offering of shares in the Company. The shares will be traded exclusive of the right to participate in a potential subsequent offering from and including today.
Ex. Date: 12 December 2024
This information is published in accordance with the requirements of the Continuing Obligations for Oslo Børs.
Contacts
Brede Ellingsæter, CFO, Thor Medical ASA, +47 472 38 440, brede.ellingseter@thormedical.com
ABOUT THOR MEDICAL ASA
Thor Medical is an emerging supplier of radionuclides, primarily alpha particle emitters, from naturally occurring thorium. Its proprietary production process requires no irradiation or use of nuclear reactors, and provides reliable, environmentally friendly, cost-efficient supply of alpha-emitters for the radiopharmaceutical industry. Thor Medical is headquartered in Oslo, Norway and listed on the Oslo Stock Exchange under the ticker symbol 'TRMED'.
